Teppei Shimamura

Dr. Teppei Shimamura


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YSYusuke Sato
Yusuke Sato
TYTetsuichi Yoshizato
Tetsuichi Yoshizato
YSYuichi Shiraishi
Yuichi Shiraishi
SMShigekatsu Maekawa
Shigekatsu Maekawa
YOYusuke Okuno
Yusuke Okuno
SOSeishi Ogawa
Seishi Ogawa

12 October 2011 in Cancer Research
Verified
Journal Article
Open access
PDF file
RKRyunosuke Kogo
Ryunosuke Kogo
TSTeppei Shimamura
Teppei Shimamura
KMKoshi Mimori
Koshi Mimori
KKKohichi Kawahara
Kohichi Kawahara
SISeiya Imoto
Seiya Imoto
MMMasaki Mori
Masaki Mori
The functional impact of recently discovered long noncoding RNAs (ncRNAs) in human cancer remains to be clarified. One long ncRNA which has attracted attention is the Hox transcript antisense intergenic RNA termed HOTAIR, a long ncRNA expressed from the developmental HOXC locus located on chromosome 12q13.13. In cooperation with Polycomb complex PRC2, the HOTAIR long ncRNA is reported to reprogram chromatin organization and promote breast cancer metastasis. In this study, we examined the status and function of HOTAIR in patients with stage IV colorectal cancer (CRC) who have liver metastases and a poor prognosis. HOTAIR expression levels were higher in cancerous tissues than in corresponding noncancerous tissues and high HOTAIR expression correlated tightly with the presence of liver metastasis. Moreover, patients with high HOTAIR expression had a relatively poorer prognosis. In a subset of 32 CRC specimens, gene set enrichment analysis using cDNA array data revealed a close correlation between expression of HOTAIR and members of the PRC2 complex (SUZ12, EZH2, and H3K27me3). Our findings suggest that HOTAIR expression is associated with a genome-wide reprogramming of PRC2 function not only in breast cancer but also in CRC, where upregulation of this long ncRNA may be a critical element in metastatic progression. Cancer Res; 71(20); 6320–6. ©2011 AACR.

5 October 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KKKeisuke Kataoka
Keisuke Kataoka
YNYasunobu Nagata
Yasunobu Nagata
AKAkira Kitanaka
Akira Kitanaka
YSYuichi Shiraishi
Yuichi Shiraishi
TSTeppei Shimamura
Teppei Shimamura
SOSeishi Ogawa
Seishi Ogawa

13 April 2015 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HSHiromichi Suzuki
Hiromichi Suzuki
KAKosuke Aoki
Kosuke Aoki
KCKenichi Chiba
Kenichi Chiba
YSYusuke Sato
Yusuke Sato
YSYusuke Shiozawa
Yusuke Shiozawa
SOSeishi Ogawa
Seishi Ogawa

18 August 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AKAyana Kon
Ayana Kon
LSLee-Yung Shih
Lee-Yung Shih
MMMasashi Minamino
Masashi Minamino
MSMasashi Sanada
Masashi Sanada
YSYuichi Shiraishi
Yuichi Shiraishi
SOSeishi Ogawa
Seishi Ogawa

1 May 2016 in Gastroenterology
Verified
Journal Article
Open access
PDF file
GSGenta Sawada
Genta Sawada
ANAtsushi Niida
Atsushi Niida
RURyutaro Uchi
Ryutaro Uchi
HHHidenari Hirata
Hidenari Hirata
TSTeppei Shimamura
Teppei Shimamura
KMKoshi Mimori
Koshi Mimori
Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer in Japan. Smoking and drinking alcohol are environmental risk factors for ESCC, whereas single nucleotide polymorphisms in ADH1B and ALDH2, which increase harmful intermediates produced by drinking alcohol, are genetic risk factors. We conducted a large-scale genomic analysis of ESCCs from patients in Japan to determine the mutational landscape of this cancer. We performed whole-exome sequence analysis of tumor and nontumor esophageal tissues collected from 144 patients with ESCC who underwent surgery at 5 hospitals in Japan. We also performed single-nucleotide polymorphism array-based copy number profile and germline genotype analyses of polymorphisms in ADH1B and ALDH2. Polymorphisms in CYP2A6, which increase harmful effects of smoking, were analyzed. Functions of TET2 mutants were evaluated in KYSE410 and HEK293FT cells. A high proportion of mutations in the 144 tumor samples were C to T substitution in CpG dinucleotides (called the CpG signature) and C to G/T substitutions with a flanking 5′ thymine (called the APOBEC signature). Based on mutational signatures, patients were assigned to 3 groups, which associated with environmental (drinking and smoking) and genetic (polymorphisms in ALDH2 and CYP2A6) factors. Many tumors contained mutations in genes that regulate the cell cycle (TP53, CCND1, CDKN2A, FBXW7); epigenetic processes (MLL2, EP300, CREBBP, TET2); and the NOTCH (NOTCH1, NOTCH3), WNT (FAT1, YAP1, AJUBA) and receptor-tyrosine kinase−phosphoinositide 3-kinase signaling pathways (PIK3CA, EGFR, ERBB2). Mutations in EP300 and TET2 correlated with shorter survival times, and mutations in ZNF750 associated with an increased number of mutations of the APOBEC signature. Expression of mutant forms of TET2 did not increase cellular levels of 5-hydroxymethylcytosine in HEK293FT cells, whereas knockdown of TET2 increased the invasive activity of KYSE410 ESCC cells. Computational analyses associated the mutations in NFE2L2 we identified with transcriptional activation of its target genes. We associated environmental and genetic factors with base substitution patterns of somatic mutations and provide a registry of genes and pathways that are disrupted in ESCCs. These findings might be used to design specific treatments for patients with esophageal squamous cancers.